Advertisement

Virchows Archiv

, Volume 451, Supplement 1, pp 61–69 | Cite as

Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms

  • Marco Volante
  • Luisella Righi
  • Sofia Asioli
  • Gianni Bussolati
  • Mauro Papotti
Review and Perspective

Abstract

Within the spectrum of neuroendocrine tumors arising in different organs, intermediate and controversial entities exist displaying a coexistence of neuroendocrine and nonneuroendocrine cell populations, and that are grouped under terms such as “goblet cell carcinoid”, “mixed endocrine-exocrine carcinoma”, “combined carcinomas”, or “adenocarcinoma with neuroendocrine differentiation”. These tumors may display variable amounts of the two components, potentially ranging from 1 to 99%, and variable structural patterns, ranging from single scattered neuroendocrine cells to a well-defined neuroendocrine tumor cell component organized in typical organoid, trabecular, or solid growth patterns. Although variably included in the site-specific World Health Organization classification schemes, clear definitions and diagnostic features are still missing, as well as a definite knowledge of their biological properties and histogenesis. In the present report, the main characteristics of tumors showing mixed neuroendocrine and nonneuroendocrine features will be described, using morphological patterns and site of origin as schematic guidelines. Moreover, molecular and clinical aspects, which might help to understand their possible histogenesis and biological behavior, will be reviewed.

Keywords

Neuroendocrine differentiation Goblet cell carcinoid Mixed neuroendocrine–exocrine carcinoma Diagnosis 

Notes

Acknowledgments

Supported by grants from the Italian Ministry of University (ex 60% to MP and MV).

Conflicts of interest statement

We declare that we have no conflict of interest.

References

  1. 1.
    Abbona G, Papotti M, Viberti L, Macri L, Stella A, Bussolati G (1998) Chromogranin A gene expression in non-small cell lung carcinomas. J Pathol 186:151–156PubMedCrossRefGoogle Scholar
  2. 2.
    al-Talib RK, Mason CH, Theaker JM (1995) Combined goblet cell carcinoid and mucinous cystadenoma of the appendix. J Clin Pathol 48:869–870PubMedCrossRefGoogle Scholar
  3. 3.
    Atasoy P, Ensari A, Demirci S, Kursun N (2003) Neuroendocrine differentiation in colorectal carcinomas: assessing its prognostic significance. Tumori 89:49–53PubMedGoogle Scholar
  4. 4.
    Aydin A, Kocer NE, Bekerecioglu M, Sari I (2003) Cutaneous undifferentiated small (Merkel) cell carcinoma, that developed synchronously with multiple actinic keratoses, squamous cell carcinomas and basal cell carcinoma. J Dermatol 30:241–244PubMedGoogle Scholar
  5. 5.
    Blumenfeld W, Chandhoke DK, Sagerman P, Turi GK (1996) Neuroendocrine differentiation in gastric adenocarcinomas. An immunohistochemical study. Arch Pathol Lab Med 120:478–481PubMedGoogle Scholar
  6. 6.
    Bollito ER, Pacchioni D, Lopez-Beltran A, Volante M, Terrone C, Casetta G, Mari M, DePompa R, Cappia S, Papotti M (2005) Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumours of the urinary bladder. Anal Quant Cytol Histol 27:218–224PubMedGoogle Scholar
  7. 7.
    Brambilla E, Lantuejoul S, Sturm N (2000) Divergent differentiation in neuroendocrine lung tumors. Semin Diagn Pathol 17:138–148PubMedGoogle Scholar
  8. 8.
    Bulliard C, Murali R, Maloof A, Adams S (2006) Endocrine mucin-producing sweat gland carcinoma: report of a case and review of the literature. J Cutan Pathol 33:812–816PubMedCrossRefGoogle Scholar
  9. 9.
    Capella C, La Rosa S, Uccella S, Billo P, Cornaggia M (2000) Mixed endocrine-exocrine tumors of the gastrointestinal tract. Semin Diagn Pathol 17:91–103PubMedGoogle Scholar
  10. 10.
    DeLellis RA, LLoyd R, Heitz PU (eds) (2004) World Health Organization classification of tumors, pathology and genetics-tumors of endocrine organs. IARC Press, LyonGoogle Scholar
  11. 11.
    Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) World Health Organization classification of tumours, pathology and genetics-tumours of the urinary system and male genital organs. IARC Press, LyonGoogle Scholar
  12. 12.
    Fernandez-Figueras MT, Puig L, Gilaberte M, Gomez-Plaza Mdel C, Rex J, Ferrandiz C, Ariza A (2002) Merkel cell (primary neuroendocrine) carcinoma of the skin with nodal metastasis showing rhabdomyosarcomatous differentiation. J Cutan Pathol 29:619–622PubMedCrossRefGoogle Scholar
  13. 13.
    Foley EF, Gaffey MJ, Frierson HF Jr (1998) The frequency and clinical significance of neuroendocrine cells within stage III adenocarcinomas of the colon. Arch Pathol Lab Med 122:912–914PubMedGoogle Scholar
  14. 14.
    Foschini MP, Eusebi V (2000) Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 17:162–168PubMedGoogle Scholar
  15. 15.
    Fujiyoshi Y, Kuhara H, Eimoto T (2005) Composite glandular-endocrine cell carcinoma of the stomach. Report of two cases with goblet cell carcinoid component. Pathol Res Pract 200:823–829PubMedCrossRefGoogle Scholar
  16. 16.
    Fukunaga M (2002) Gastric carcinoma resembling pancreatic mixed acinar-endocrine carcinoma. Human Pathol 33:569–573CrossRefGoogle Scholar
  17. 17.
    Furlan D, Cerutti R, Genasetti A, Pelosi G, Uccella S, La Rosa S, Capella C (2003) Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut. Lab Invest 83:963–971PubMedCrossRefGoogle Scholar
  18. 18.
    George E, Swanson PE, Wick MR (1989) Neuroendocrine differentiation in basal cell carcinoma. An immunohistochemical study. Am J Dermatopathol 11:131–135PubMedGoogle Scholar
  19. 19.
    Goddard MJ, Lonsdale RN (1992) The histogenesis of appendiceal carcinoid tumours. Histopathology 20:345–349PubMedCrossRefGoogle Scholar
  20. 20.
    Golouh R, Us-Krasovec M, Auersperg M, Jancar J, Bondi A, Eusebi V (1985) Amphicrine—composite calcitonin and mucin-producing—carcinoma of the thyroid. Ultrastruct Pathol 8:197–206PubMedCrossRefGoogle Scholar
  21. 21.
    Grabowski P, Schindler I, Anagnostopoulos I, Foss HD, Riecken EO, Mansmann U, Stein H, Berger G, Buhr HJ, Scherubl H (2001) Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol 13:405–411PubMedCrossRefGoogle Scholar
  22. 22.
    Grabowski P, Schonfelder J, Ahnert-Hilger G, Foss HD, Heine B, Schindler I, Stein H, Berger G, Zeitz M, Scherubl H (2002) Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum. Virchows Arch 441:256–263PubMedCrossRefGoogle Scholar
  23. 23.
    Hamilton SR, Aaltonen L (2000a) World Health Organization classification of tumors. Pathology and genetics—tumors of the digestive system. IARC Press, LyonGoogle Scholar
  24. 24.
    Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K (2000b) Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Mod Path 13:475–481CrossRefGoogle Scholar
  25. 25.
    Helpap B, Kloppel G (2002) Neuroendocrine carcinomas of the prostate and urinary bladder: a diagnostic and therapeutic challenge. Virchows Arch 440:241–248PubMedCrossRefGoogle Scholar
  26. 26.
    Hishima T, Fukayama M, Hayashi Y, Fujii T, Arai K, Shiozawa Y, Funata N, Koike M (1998) Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma. Human Pathol 29:330–338CrossRefGoogle Scholar
  27. 27.
    Hong SM, Kim MJ, Pi DY, Jo D, Yu E, Ro JY (2005) Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Human Pathol 36:732–740CrossRefGoogle Scholar
  28. 28.
    Howe MC, Chapman A, Kerr, K, Dougal M, Anderson H, Hasleton PS (2005) Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology 46:195–201PubMedCrossRefGoogle Scholar
  29. 29.
    Huang J, Behrens C, Wistuba II, Gazdar AF, Jagirdar J (2002) Clonality of combined tumors. Arch Pathol Lab Med 126:437–441PubMedGoogle Scholar
  30. 30.
    Indinnimeo M, Cicchini C, Memeo L, Stazi A, Provenza C, Ricci F, Mingazzini PL (2002) Correlation between chromogranin-A expression and pathological variables in human colon carcinoma. Anticancer Res 22:395–398PubMedGoogle Scholar
  31. 31.
    Jain D, Eslami-Varzaneh F, Takano A, Ayer U, Umashankar R, Muller R, Klimstra D (2005) Composite glandular and endocrine tumors of the stomach with pancreatic acinar differentiation. Am J Surg Pathol 29:1524–1529PubMedCrossRefGoogle Scholar
  32. 32.
    Jiao YF, Nakamura S, Arai T, Sugai T, Uesugi N, Habano W, Suzuki M, Tazawa H, Goukon Y (2003) Adenoma, adenocarcinoma and mixed carcinoid–adenocarcinoma arising in a small lesion of the colon. Pathol Int 53:457–462PubMedCrossRefGoogle Scholar
  33. 33.
    Kanthan R, Saxena A, Kanthan SC (2001) Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med 125:386–390PubMedGoogle Scholar
  34. 34.
    Kashima K, Yokoyama S, Inoue S, Daa T, Kodama M, Nakayama I, Noguchi S (1993) Mixed medullary and follicular carcinoma of the thyroid: report of two cases with an immunohistochemical study. Acta Pathol Jpn 43:428–433PubMedGoogle Scholar
  35. 35.
    Kim KM, Kim MJ, Cho BK, Choi SW, Rhyu MG (2002) Genetic evidence for the multi-step progression of mixed glandular-neuroendocrine gastric carcinomas. Virchows Arch 440:85–93PubMedCrossRefGoogle Scholar
  36. 36.
    Klimstra DS, Rosai J, Heffess C (1994) Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 18:765–778PubMedCrossRefGoogle Scholar
  37. 37.
    Kloppel G (2000) Mixed exocrine-endocrine tumors of the pancreas. Semin Diagn Pathol 17:104–108PubMedGoogle Scholar
  38. 38.
    Kovacs CS, Mase RM, Kovacs K, Nguyen GK, Chik CL (1994) Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B. Cancer 74:928–932PubMedCrossRefGoogle Scholar
  39. 39.
    Kuo TT (2000) Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study. Histopathology 37:19–26PubMedCrossRefGoogle Scholar
  40. 40.
    Lauriola L, Erlandson RA, Rosai J (1998) Neuroendocrine differentiation is a common feature of thymic carcinoma. Am J Surg Pathol 22:1059–1066PubMedCrossRefGoogle Scholar
  41. 41.
    Lewin K (1987) Carcinoid tumors and the mixed (composite) glandular-endocrine cell carcinomas. Am J Surg Pathol 11:71–76PubMedCrossRefGoogle Scholar
  42. 42.
    Li CC, Hirowaka M, Qian ZR, Xu B, Sano T (2002) Expression of E-cadherin, b-catenin, and Ki-67 in goblet cell carcinoids of the appendix: an immunohistochemical study with clinical correlation. Endocr Pathol 13:47–58PubMedCrossRefGoogle Scholar
  43. 43.
    Mizukami Y, Michigishi T, Nonomura A, Nakamura S, Noguchi M, Hashimoto T, Itoh N (1993) Mixed medullary-follicular carcinoma of the thyroid occurring in familial form. Histopathology 22:284–287PubMedCrossRefGoogle Scholar
  44. 44.
    Mizuno T, Masaoka A, Hashimoto T, Shibata K, Yamakawa Y, Torii K, Fukai I, Ito K (1990) Coexisting thymic carcinoid tumor and thymoma. Ann Thorac Surg 50:650–652PubMedCrossRefGoogle Scholar
  45. 45.
    Modlin IM, Kidd M, Latich I, Zikusoka MN, Eick GN, Mane SM, Camp RL (2006) Genetic differentiation of appendiceal tumor malignancy: a guide for the perplexed. Ann Surg 244:52–60PubMedCrossRefGoogle Scholar
  46. 46.
    Moran CA, Suster S (2000) Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases. Am J Clin Pathol 113:345–350PubMedCrossRefGoogle Scholar
  47. 47.
    Noel M, Delehaye MC, Segond N, Lasmoles F, Caillou B, Gardet P, Fragu P, Moukhtar MS (1991) Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma. Thyroid 1:249–256PubMedCrossRefGoogle Scholar
  48. 48.
    Noske A, Pahl S (2006) Combined adenosquamous and large-cell neuroendocrine carcinoma of the gallbladder. Virchows Arch 449:135–136PubMedCrossRefGoogle Scholar
  49. 49.
    Ohike N, Jurgensen A, Pipeleers-Marichal M, Kloppel G (2003) Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells. Virchows Arch 442:258–265PubMedGoogle Scholar
  50. 50.
    Ohike N, Kosmahl M, Kloppel G (2004) Mixed acinar-endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 445:231–235PubMedCrossRefGoogle Scholar
  51. 51.
    Ooi A, Hayashi H, Katsuda S, Nakanishi I (1992) Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation. Human Pathol 23:736–741CrossRefGoogle Scholar
  52. 52.
    Orlandi F, Chiefari E, Caraci P, Mussa A, Gonzatto I, De Giuli P, Giuffrida D, Angeli A, Filetti S (2001) RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma. J Endocrinol Invest 24:51–55PubMedGoogle Scholar
  53. 53.
    Pagani A, Papotti M, Abbona GC, Bussolati G (1995) Chromogranin gene expression in colorectal adenocarcinomas. Mod Path 8:626–632Google Scholar
  54. 54.
    Papotti M, Galliano D, Monga G (1990) Signet ring cell carcinoid of the gallbladder. Histopathology 17:255–259PubMedCrossRefGoogle Scholar
  55. 55.
    Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV (1997) Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch 430:397–405PubMedCrossRefGoogle Scholar
  56. 56.
    Papotti M, Volante M, Komminoth P, Sobrinho-Simoes M, Bussolati G (2000) Thyroid carcinomas with mixed follicular and C-cell differentiation patterns. Semin Diagn Pathol 17:109–119PubMedGoogle Scholar
  57. 57.
    Pasquinelli G, Santini D, Preda P, Cariani G, Bonora G, Martinelli GN (1993) Composite gastric carcinoma and precursor lesions with amphicrine features in chronic atrophic gastritis. Ultrastruct Pathol 17:9–24PubMedCrossRefGoogle Scholar
  58. 58.
    Paties C, Zangrandi A, Vassallo G, Rindi G, Solcia E (1991) Multidirectional carcinoma of the thymus with neuroendocrine and sarcomatoid components and carcinoid syndrome. Pathol Res Pract 187:170–177PubMedGoogle Scholar
  59. 59.
    Ramnani DM, Wistuba II, Behrens C, Gazdar AF, Sobin LH, Albores-Saavedra J (1999) K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. Cancer 86:14–21PubMedCrossRefGoogle Scholar
  60. 60.
    Righi L, Volante M, Rapa I, Scagliotti GV, Papotti M (2007) Neuroendocrine tumors of the lung: a review of relevant pathological and molecular data Virchows Arch (current issue)Google Scholar
  61. 61.
    Rossi G, Bertolini F, Sartori G, Bigiani N, Cavazza A, Foroni M, Valli R, Rindi G, De Gaetani C, Luppi G (2004) Primary mixed adenocarcinoma and small cell carcinoma of the appendix: a clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. Am J Surg Pathol 28:1233–1239PubMedCrossRefGoogle Scholar
  62. 62.
    Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G (2000) Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17:127–137PubMedGoogle Scholar
  63. 63.
    Solcia E, Kloppel G, Sobin LH (2000) World Health Organization International histological classification of tumors. Histological typing of endocrine tumors. Springer, Berlin Heidelberg New York, pp 56–68Google Scholar
  64. 64.
    Stancu M, Wu TT, Wallace C, Houlihan PS, Hamilton SR, Rashid A (2003) Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Path 16:1189–1198CrossRefGoogle Scholar
  65. 65.
    Stinner B, Rothmund M (2005) Neuroendocrine tumours (carcinoids) of the appendix. Best Pract Res Clin Gastroenterol 19:729–738PubMedCrossRefGoogle Scholar
  66. 66.
    Subbuswamy SG, Gibbs NM, Ross CF, Morson BC (1974) Goblet cell carcinoid of the appendix. Cancer 34:338–344PubMedCrossRefGoogle Scholar
  67. 67.
    Sugita K, Yamamoto O, Hamada T, Hisaoka M, Tokura Y (2004) Primary apocrine adenocarcinoma with neuroendocrine differentiation occurring on the pubic skin. Br J Dermatol 150:371–373PubMedCrossRefGoogle Scholar
  68. 68.
    Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours. Pathology and genetics—tumours of the breast. IARC Press, Lyon, 32–34Google Scholar
  69. 69.
    Terada T, Matsunaga Y, Maeda H, Endo K, Horie S, Ohta T (1999) Mixed ductal-endocrine carcinoma of the pancreas presenting as gastrinoma with Zollinger-Ellison syndrome: an autopsy case with a 24-year survival period. Virchows Archiv 435:606–611PubMedCrossRefGoogle Scholar
  70. 70.
    Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization classification of tumors, pathology and genetics-tumors of the lung, pleura, thymus and heart. IARC Press, LyonGoogle Scholar
  71. 71.
    Ubiali A, Benetti A, Papotti M, Villanacci V, Rindi G (2001) Genetic alterations in poorly differentiated endocrine colon carcinomas developing in tubulo-villous adenomas: a report of two cases. Virchows Arch 439:776–781PubMedGoogle Scholar
  72. 72.
    Volante M, Papotti M, Roth J, Saremaslani P, Speel EJ, Lloyd RV, Carney JA, Heitz PU, Bussolati G, Komminoth P (1999) Mixed medullary-follicular thyroid carcinoma: molecular evidence for a dual origin of tumor components. Am J Pathol 155:1499–1509PubMedGoogle Scholar
  73. 73.
    Volante M, Sapino A, Papotti M, Pacchioni D, Bussolati G (2004) Neuroendocrine differentiation patterns in various organs (including lung, breast, skin, and urogenital tract). In: RV Lloyd (ed) Endocrine pathology. Differential diagnosis and molecular advances. Humana Press, Totowa, USA, 345–358Google Scholar
  74. 74.
    Volante M, Rindi G, Papotti M (2006) The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch 449:499–506PubMedCrossRefGoogle Scholar
  75. 75.
    Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, Zhuang Z (1997) Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 89:1448–1453PubMedCrossRefGoogle Scholar
  76. 76.
    Warkel RL, Cooper PH, Helwig EB (1978) Adenocarcinoid, a mucin-producing carcinoid tumor of the appendix: a study of 39 cases. Cancer 42:2781–2793PubMedCrossRefGoogle Scholar
  77. 77.
    Yang GC, Rotterdam H (1991) Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature. Am J Surg Pathol 15:592–598PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Marco Volante
    • 1
  • Luisella Righi
    • 1
  • Sofia Asioli
    • 2
  • Gianni Bussolati
    • 2
  • Mauro Papotti
    • 1
  1. 1.Department of Clinical and Biological SciencesUniversity of Turin and San Luigi HospitalOrbassanoItaly
  2. 2.Department of Biomedical Sciences and Human OncologyUniversity of TurinTurinItaly

Personalised recommendations